loratadine and pseudoephedrine, Claritin-D (cont.)
DRUG INTERACTIONS: Claritin-D should not be taken at the same time as or within 14 days of monoamine oxidase (MAO) inhibiting drugs.
PREGNANCY: The decongestant pseudoephedrine causes birth defects in some animal species. Additionally, there have been associations between first trimester exposure to these medications and malformations in the fetus, primarily minor malformations. Thus, Claritin-D should be used in pregnancy only if the physician feels that the potential benefit outweighs the risk.
NURSING MOTHERS: Pseudoephedrine is secreted in breast milk. The American Academy of Pediatrics considers pseudoephedrine to be compatible with nursing.
SIDE EFFECTS: Side effects of Claritin-D include stimulation of the nervous system leading to nervousness, restlessness, excitability, dizziness, headache, fear, anxiety, tremor, and even hallucinations and convulsions (seizures).
Reference: FDA Prescribing Information
Last Editorial Review: 4/17/1999
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Back to Medications Index